ARTICLE | Clinical News
Paquinimod regulatory update
May 5, 2014 7:00 AM UTC
Active Biotech disclosed in its 1Q14 earnings that in January FDA granted Orphan Drug designation to paquinimod to treat systemic sclerosis. The small molecule quinoline-3-carboxamide immunomodulator ...